Chemotherapy with a tp regimen in combination with stereotactic radiotherapy could significantly optimize the clinical efficacy of nsclc treatment

HIGHLIGHTS

  • who: Chenglin Wu et al. from the Department of Respiratory and Critical Care Medicine, Shiyan Taihe Hospital, Shiyan, Hubei, China have published the article: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment, in the Journal: Evidence-Based Complementary and Alternative Medicine of 14/06/2022
  • what: The aim of this study is to investigate the clinical efficacy of stereotactic radiotherapy in combination with a docetaxel plus cisplatin (TP) chemotherapy regimen in patients with nonsmall cell lung cancer (NSCLC) and their impact on the levels . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?